Literature DB >> 6247622

Trypsin action on the growth of Sendai virus in tissue culture cells. V. An activating enzyme for Sendai virus in the chorioallantoic fluid of the embryonated chicken egg.

M Muramatsu, M Homma.   

Abstract

A trypsin-like protease which is responsible for activation of Sendai virus was found in the chorioallantoic fluid (CAF) of embryonated chicken eggs. Treatment of the inactive form of Sendai virus, grown in LLC-MK2 cells, with CAF enhanced both hemolytic activity and infectivity for the cells. Soybean trypsin inhibitor restrained the enhancing activity of CAF. These results indicate that CAF contains a trypsin-like protease which activates the inactive form of Sendai virus. The activation was strongly inhibited by phenylmethylsulfonylfluoride, ethylenediaminetetraacetate, antipain, and leupeptin but not by tosyllysylchloromethylketone, suggesting that the activating enzyme in CAF is a protease similar to but not identical with trypsin. The inactive form of the virion was produced in ovo when the seed virus was inoculated along with antipain or leupeptin. In deembryonated chicken eggs in which CAF was substituted for a culture medium, multiple cycle growth occurred, but not when soybean trypsin inhibitor was present. These observations indicate that some activating enzyme, possibly the same one as found in CAF, was secreted from the chorioallantoic membrane.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247622     DOI: 10.1111/j.1348-0421.1980.tb00569.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  23 in total

1.  Significance of basolateral domain of polarized MDCK cells for Sendai virus-induced cell fusion.

Authors:  M Tashiro; M Yamakawa; K Tobita; H D Klenk; J T Seto; R Rott
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide.

Authors:  R G Paterson; M A Shaughnessy; R A Lamb
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.

Authors:  M Itoh; T D Ming; T Hayashi; Y Mochizuki; M Homma
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

4.  Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus.

Authors:  Joanna Rawling; Olga Cano; Dominique Garcin; Daniel Kolakofsky; José A Melero
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

Review 5.  Protease-dependent virus tropism and pathogenicity.

Authors:  Y Nagai
Journal:  Trends Microbiol       Date:  1993-06       Impact factor: 17.079

6.  A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.

Authors:  X L Wang; M Itoh; H Hotta; M Homma
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2.

Authors:  M Tashiro; M Homma
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

Authors:  M Tashiro; Y Yokogoshi; K Tobita; J T Seto; R Rott; H Kido
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs.

Authors:  M Tashiro; Y Beppu; K Sakai; H Kido
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.